Stock Analysis

Axcelis Technologies (NasdaqGS:ACLS) Sees 15% Drop As Q4 Revenue Falls To US$252M

Published

Axcelis Technologies (NasdaqGS:ACLS) recently showcased its Purion platform at SEMICON Korea 2025, focusing on advanced ion implantation technologies for semiconductor manufacturing. Despite the company's efforts to highlight its innovations, Axcelis's stock experienced a price decline of 15% over the past week. This drop coincided with the release of its fiscal Q4 2024 earnings report, which revealed a year-on-year revenue reduction from $310 million to $252 million, alongside a fall in net income and basic earnings per share to $1.54. This financial update seemed to have overshadowed product announcements, contributing to concerns about the company's profitability. The stock's performance also occurred within a broader market trend, with the Nasdaq down 5.5% in February, reflecting overall uncertainties in the tech sector. As investors cautiously reacted to these developments, broader market dynamics and economic factors may have compounded challenges for Axcelis, influencing its on-market returns.

Take a closer look at Axcelis Technologies's potential here.

NasdaqGS:ACLS Earnings Per Share Growth as at Feb 2025

Over the last five years, Axcelis Technologies's shares have achieved a total return of 137.07%, showcasing a strong performance. This positive trajectory can be attributed to several pivotal factors. The company's consistent focus on high-quality earnings, despite recent earnings downturns, has provided some resilience. Corporate developments, such as the appointment of Russell J. Low as CEO in May 2023, have played a role in steering the company through the evolving semiconductor landscape. Furthermore, Axcelis's strategic share buyback program, initiated in March 2022, underscores its confidence in long-term value creation for shareholders.

In contrast, Axcelis underperformed over the past year compared to both the broader US market and the semiconductor industry. The anticipated challenges, as reflected in recent earnings guidance and negative growth forecasts for the coming three years, have increased investor caution. Despite expected revenue declines, Axcelis's shares are valued attractively based on its Price-To-Earnings Ratio, which may offer an appealing entry point for some investors observing these broader market trends.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com